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A B S T R A C T
Objective: To analyse the effect of treatment method and other risk factors on survival in dogs with cranial
cruciate ligament disease (CCLD).
Methods: A historical cohort study of 333 dogs presenting with CCLD at two University Hospitals (2011–2016)
was performed. Signalment, history, treatment and follow-up details were retrieved from medical records, dog
owners and referring veterinarians. Treatment groups were defined; conservative or surgical with either lateral
fabellotibial suture (LFS) or osteotomy procedures. Multivariable Cox proportional hazards models were applied
to evaluate risk factors for disease-related and overall survival.
Results: Sixty-five dogs were conservatively managed, 125 treated with LFS and 143 with osteotomy techniques.
At follow-up (autumn 2018), 164 dogs (49.3 %) were alive and 169 (50.7 %) were dead. Both final Cox pro-
portional hazards models included variables for treatment, age, weight and hospital. In addition, the final dis-
ease-related model included a variable for orthopaedic comorbidity, while non-orthopaedic comorbidities and a
time-varying effect for age on a linear scale were included in the overall survival model. Treatment method was
found to have an effect on both disease-related and overall survival and surgical treatment was associated with a
lower hazard than conservative treatment.
Conclusion: Survival in dogs with CCLD is influenced by treatment strategy, comorbidities, age and weight.
1. Introduction
Cranial cruciate ligament disease (CCLD) is one of the most common
orthopaedic conditions in dogs (Johnson et al., 1994). Many factors
including anatomical configuration, genetic and environmental factors
are thought to affect the development of CCLD, but the exact aetio-
pathogenesis is still unclear (Whitehair et al., 1993; Duval et al., 1999;
Witsberger et al., 2008; Taylor-Brown et al., 2015). The disease can be
treated either conservatively or surgically, and osteoarthritis progresses
in the affected joint regardless of treatment method (Schulz, 2012).
More than 60 variations of surgical procedures have been described
(Bergh et al., 2014), including lateral fabellotibial suture stabilisation
(LFS), tibial plateau levelling osteotomy (TPLO) and tibial tuberosity
advancement techniques such as the tibial tuberosity advancement
(TTA) and the modified Maquet procedure (MMP). The most studied
procedures are TPLO and LFS, followed by TTA, and there are only a
few studies comparing long-term outcomes for more than two surgical
techniques (Moore and Read, 1995; Conzemius et al., 2005; Christopher
et al., 2013; Bergh et al., 2014; Mölsä et al., 2014). Although no general
agreement on which surgical method yields the best outcome exists,
there is some evidence in favour of TPLO according to a systematic
review by Bergh et al. (2014). Only a limited number of studies have
evaluated the outcome after conservative treatment (Pond and
Campbell, 1972; Vasseur, 1984; Wucherer et al., 2013).
Most studies assessing the outcome after surgical treatment of CCLD
have a follow-up time of less than six months and/or focus on risk
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factors for postoperative complications (Pacchiana et al., 2003; Stauffer
et al., 2006; Fitzpatrick and Solano, 2010; Bergh et al., 2014; Hans
et al., 2017). Information obtained from dog owner interviews/ques-
tionnaires and visual gait observation is commonly used for assessment
of long-term outcome, while objective measurements such as force
plate gait analysis and thigh circumference are less often reported
(Bergh et al., 2014). In addition, several outcome evaluation tools
aiming to incorporate different aspects of the clinical picture have been
developed in recent years (Hyytiainen et al., 2018; Pinna et al., 2019).
Common to all outcome measurement tools is that they aim to evaluate
the degree of lameness, chronic pain or loss of function in the affected
hind limb. This could potentially result in euthanasia in severe cases, if
the degree of pain and loss of function is deemed unacceptable. How-
ever, there are currently no studies evaluating the effect of treatment
strategy on life expectancy in dogs with CCLD, hence the risk of eu-
thanasia in dogs with the disease is unknown.
The main objective of the current study was to estimate the effect of
treatment method, other risk factors and potential confounders on
survival in dogs with CCLD. We hypothesised that surgically treated
dogs would have a favourable outcome compared to dogs treated
conservatively.
2. Materials and methods
2.1. Study design
A historical cohort study was performed utilising electronic medical
records of dogs with CCLD examined at two referral Veterinary
University Hospitals (VHs) in Uppsala, Sweden and Oslo, Norway be-
tween January 1st, 2011 and December 31st, 2016.
2.2. Data collection
The medical records were reviewed between January 1st and August
31st, 2018. Routine clinical data, including history, age, breed, sex,
body weight and treatment method, was retrieved. Neuter status and
orthopaedic examination findings were registered in all records and
hence not included. Although inconsistently recorded in the medical
records, standardised written postoperative care and rehabilitation re-
commendations were available at both VHs and routinely provided to
owners.
Follow-up information regarding additional complications, con-
tralateral CCLD and date and reason for death/euthanasia was obtained
from the medical records and by standardised telephone interviews
with the owners between August 1st and October 15th, 2018.
Furthermore, if additional information was needed, referring veter-
inarians were contacted (i.e. owner could not remember date or cause
of euthanasia). Dates were recorded as 1st of the month if the exact date
was unknown.
Inclusion criteria was a diagnosis of CCLD confirmed by either a
positive cranial drawer test, a positive tibial thrust or by visual in-
spection of a ruptured cranial cruciate ligament by arthroscopy or ar-
throtomy. Exclusion criteria were: missing information about duration
of lameness before treatment initiation, euthanasia at time of diagnosis,
less than 14 days follow-up time, concurrent collateral ligament rup-
ture, joint inspection revealing less than 10 % CCL rupture, diagnosis at
the VHs but surgical treatment at another clinic, and surgical treatment
of contralateral CCLD at the VHs prior to the study period.
2.3. Outcome
Reasons for death/euthanasia were retrospectively classified.
Euthanasia related to CCLD was defined as all deaths where owners
stated lameness from the affected hindlimb(s) as contributing to the
decision of euthanasia. It was classified by the authors into five dif-
ferent subcategories; persistent lameness, subsequent contralateral
CCLD, postoperative complications, guarded prognosis for return to full
function, and other reasons. Classification of death/euthanasia un-
related to CCLD was performed according to Fleming et al. (2011), with
a few modifications: the original categories for organ system and pa-
thophysiological process were used, but additional categories for “high
age” and “behaviour-related” were added. If the reason for death/eu-
thanasia could not be classified, it was recorded as “unclassified” rather
than excluded.
Factors related to the dog, the owner and the examining veter-
inarian can influence the decision of euthanasia, and hence, classifi-
cation of cause of death can be uncertain. Consequently, analysis of
overall survival was included to confirm the validity of the disease-
related survival analysis.
2.4. Risk factors
Treatment method was defined as the main exposure variable. All
dogs without surgical correction of CCLD were defined as con-
servatively treated. Surgically treated dogs were categorised into two
treatment groups; LFS and osteotomy (TPLO, TTA and MMP).
A tentative causal diagram was made to identify possible con-
founding and intervening variables for the association of treatment
method with the outcome. In addition, a change of> 20 % in the
coefficients in the statistical model with the potential confounder pre-
sent was used to assess confounding. All post-surgical related variables
(such as postoperative complications and subsequent contralateral
CCLD) were considered as intervening variables, and thus not con-
sidered for inclusion in the statistical analyses. The variables hospital,
age, sex, weight, orthopaedic and non-orthopaedic comorbidities
(present at the time of treatment initiation), lameness more than eight
weeks prior to treatment initiation, insurance status, overweight (body
condition score> 5/9,> 3/5 or subjectively judged as overweight by
the examining veterinarian), laterality of the affected stifle, and joint
exploration were considered as potential determinants for survival. The
variable for orthopaedic comorbidity included separate categories for
common causes of hindlimb lameness; patellar luxation, stifle os-
teochondrosis, hip dysplasia, in addition to other orthopaedic condi-
tions.
2.5. Statistical analysis
All statistical analyses were conducted in Stata 15 (StataCorp,
2017). Graphical assessment of the continuous variables showed de-
viance from normality, hence continuous variables are presented as
median (range). Categorical variables are presented as number (per-
centage). The one-sample test of proportions was used to compare the
number of female and male dogs. Dogs with concurrent or subsequent
contralateral CCLD were included as a single case at the time of first
CCLD treatment at the VHs. Kaplan-Meier survival curves were used to
describe differences in time-to-event for the treatment groups and the
median time-to-event and censoring was calculated. Follow-up time
was defined as the time from treatment initiation to death/euthanasia,
or owner-contact/latest follow-up in the medical records when the dog
was alive. Maximum follow-up time was set to 6 years (72 months) for
the analyses.
Cox proportional hazards models were applied to estimate the effect
of possible risk factors for disease-related and overall survival. Dogs
alive at the end of the study period or lost to follow-up were censored.
In addition, dogs that were dead/euthanised due to causes unrelated to
CCLD were censored in the disease-related survival analysis. A single
missing value was identified; a female Gordon setter without body-
weight recorded. In this case, the average bodyweight for female
Gordon setters according to the breed standard2 was used in the
2 Fédération Cynologique Internationale breed standard Gordon setter,
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analysis. Collinearity between variables was evaluated by Goodman
and Kruskal’s gamma for categorical or dichotomous variables and by
Spearman rank-order correlation coefficient for continuous variables. A
coefficient, hazard ratio (HR), its 95 % confidence interval and p-value,
were calculated for each variable. All variables with p < 0.15 in uni-
variable analyses were considered for inclusion in the multivariable
models. A fixed effect for hospital was forced into the final models to
account for differences between the two VHs.
A p-value of< 0.05 was considered statistically significant and
manual stepwise backward elimination was applied for selection of
variables. The Wald test was used to evaluate the significance of the
predictors. Biologically plausible interactions were considered for in-
clusion. Schoenfeld residuals for each variable in the final models were
used to evaluate the assumption of proportional hazards. If a violation
of the proportional hazards assumption was identified and graphical
assessment indicated a time-varying effect (TVE) of a variable, an in-
teraction term between the variable and time on the appropriate scale
was included in the model. Sensitivity analysis was performed to
evaluate the assumption of individual censoring. Plots of martingale
residuals were used to test the functional form of the predictors.
Deviance and scaled score residuals were plotted against time at risk for
detection of outliers and influential observations, respectively. The
models were fit with and without the suspected outlying observations.
Linear combinations of the coefficients from the models were used to
check for differences between the treatment methods after the final
models were fitted.
3. Results
3.1. Animals and treatment
Of the initial 436 dogs with CCLD identified within the study period,
333 (Hospital 1: 121, Hospital 2: 212) met the inclusion criteria and
were enrolled in the study (see Table 1 for descriptive features). The
most common breeds were mixed-breed (n= 66), Rottweiler (n=24),
Labrador Retriever (n=15), Golden Retriever (n=15) and Jack
Russel Terrier (n= 13). There were more female than male dogs
(p= 0.03). Of the 333 dogs, 65 (19.5 %) were conservatively treated,
125 (37.6 %) treated with LFS and 143 (42.9 %) treated with an os-
teotomy technique (71 TPLOs, 54 TTAs, 18 MMPs).
In total, 134/333 dogs (40.2 %) had a comorbidity recorded at the
time of treatment initiation. The most common orthopaedic and non-
orthopaedic comorbidities were patellar luxation and dermatological
disease, respectively. Of the conservatively treated dogs, 18/65 (27.7
%) had concurrent orthopaedic conditions while 20/65 (30.8 %) had
other non-orthopaedic diseases. The corresponding numbers for the LFS
group were 34/125 (27.2 %) and 19/125 (15.2 %), and for the os-
teotomy group 30/143 (21.0 %) and 24/143 (16.8 %), respectively.
3.2. Outcome
At follow-up, 164/333 dogs (49.3 %) were still alive, while 169/333
(50.7 %) were dead or euthanised; 61/333 (18.3 %) of disease-related
causes. Nineteen of the 65 (29.2 %) dogs in the conservatively treated
group were dead due to disease-related causes, with corresponding
numbers 19/125 (15.2 %) in the LFS group and 23/143 (16.1 %) in the
osteotomy group (Table 2). Concurrent comorbidities contributed to the
decision in 9/19 (47.4 %) conservatively treated dogs, 6/19 (31.6 %)
dogs treated by LFS and 7/23 (30.4 %) dogs treated with osteotomy.
None of the dogs excluded due to< 14 days follow-up time were re-
corded as dead/euthanised. The most common disease-related reason
for euthanasia was persistent lameness (see Table 3 for further details).
The most common non-disease-related reasons were high age or related
to the urogenital organs, gastrointestinal system or the musculoskeletal
system (lameness of the affected hindlimb excluded).
3.3. Survival analysis
Kaplan-Meier survival curves for disease-related and overall sur-
vival in the different treatment groups are presented in Fig. 1. Colli-
nearity between variables was not detected.
The final multivariable disease-related survival model included
Table 1
Descriptive features at time of diagnosis of 333 dogs with cranial cruciate ligament disease (2011-2016).
Variable Surgery Conservative Total
LFS Osteotomy
Number of dogs (% of overall) 125 (37.5) 143 (43.0) 65 (19.5) 333 (100.0)
Dogs treated at Hospital 1 25 (20.0) 77 (53.9) 19 (29.2) 121 (36.3)
Dogs treated at Hospital 2 100 (80.0) 66 (46.2) 46 (70.8) 212 (63.7)
Age in years (min-max) 7.7 (0.9−12.8) 4.2 (0.9−10.7) 7.6 (0.2−13.3) 6.5 (0.2−13.3)
Weight in kg (min-max)† 11.3 (3.3−49.3) 35.0 (10.1−80.3) 17.9 (3.8−76.0) 23.6 (3.3−80.3)
Overweight (%) 41 (32.8) 35 (24.5) 19 (29.2) 95 (28.5)
Sex (%)
Female 74 (59.2) 71 (49.7) 40 (61.5) 185 (55.6)
Male 51 (40.8) 72 (51.3) 25 (38.5) 148 (44.4)
Insured (%) 112 (89.6) 118 (82.5) 52 (80.0) 282 (84.3)
Stifle affected (%)
Left 60 (48.0) 82 (57.3) 28 (43.1) 170 (51.0)
Right 62 (49.6) 59 (41.3) 34 (52.3) 155 (46.6)
Bilateral 3 (2.4) 2 (1.4) 3 (4.6) 8 (2.4)
Lameness >8w prior to treatment initiation (%) 47 (37.6) 74 (51.8) 33 (50.8) 154 (46.3)
Orthopaedic comorbidities (%) 34 (27.2) 30 (21.0) 18 (27.7) 82 (24.61)
Hip dysplasia 7 (5.6) 9 (6.3) 2 (3.1) 18 (5.4)
Patellar luxation 19 (15.2) 2 (1.4) 5 (7.7) 26 (7.8)
OC Stifle 0 (0.0) 7 (4.9) 4 (6.2) 11 (3.3)
Other 8 (6.4) 12 (8.4) 7 (10.8) 27 (8.1)
Non-orthopaedic comorbidities (%) 19 (15.2) 24 (16.8) 20 (30.8) 63 (18.9)
Categorical variables presented as number of dogs (% total number of dogs by treatment method if not specified). Continuous variables as median (min-max)..
LFS=Lateral Fabellotibial suture; OC=Osteochondrosis.
† Weight missing for one dog, N=332.
(footnote continued)
accessed 13.02.2019: http://www.fci.be/Nomenclature/Standards/006g07-
en.pdf
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variables for treatment method, orthopaedic comorbidities, age, weight
and hospital (Table 4). The hazard for dogs treated by osteotomy was
lower than for the conservatively treated dogs (HR 0.40, p= 0.012). It
was also lower for the dogs treated by LFS (HR 0.56, p=0.109). No
statistical difference was found between LFS and osteotomies
(p=0.370). The hazard increased with other orthopaedic comorbid-
ities (HR 3.09, p= 0.001), increasing age (HR 1.12, p= 0.039) and
increasing body weight (HR 1.03, p=0.001). The model validation for
the disease-related survival model did not reveal violations of the
model assumptions.
In the final multivariable overall survival model, the assumption of
proportional hazards was violated for age. The graphical assessment
indicated that the effect of age increased on a linear time scale. Thus, a
TVE interaction between age and time was included in the overall
survival model. The variables for treatment method, non-orthopaedic
Table 2
Treatment and follow-up details of 333 dogs with cranial cruciate ligament disease (2011-2016).
Variable Surgery Conservative Total
LFS (N=125) Osteotomy (N=143) (N=65) (N=333)
Follow-up time in months (min-max) 34.0 (0.8−91.3) 36 (0.5−89.3) 23.5 (0.6−90.4) 34 (0.5−91.3)
Bilateral rupture (% of dogs with unilateral CCLD)* 47 (38.5) 49 (34.8) 10 (16.1) 106 (32.6)
Joint inspection (%) 115 (92.0) 104 (72.7) 5 (7.7) 224 (67.3)
Hospital 1 16 (64.0) 38 (49.4) 4 (21.1) 58 (47.9)
Hospital 2 99 (99.0) 66 (100.0) 1 (2.2) 166 (78.3)
Arthrotomy (%) 101 (80.1) 42 (29.4) 2 (3.1) 145 (43.5)
Arthroscopy (%) 21 (16.8) 73 (51.1) 3 (4.6) 97 (29.1)
Meniscal injuries (%) 29 (23.2) 29 (20.3) 1 (1.5) 59 (17.7)
Post-operative complications (%) 32 (25.6) 52 (36.4) NA NA
Dogs alive (%) 69 (55.2) 76 (53.2) 19 (29.3) 164 (49.3)
Dogs dead/euthanised (%) 56 (44.8) 67 (46.8) 46 (70.7) 169 (50.7)
CCLD-related 19 (15.2) 23 (16.1) 19 (29.2) 61 (18.3)
Other causes 37 (29.6) 44 (30.7) 27 (41.5) 108 (32.4)
Months to CCLD-related euthanasia (min-max) 19.9 (2.3−45.1) 21.9 (0.5−68.1) 2.4 (0.6−74.0) 15.6 (0.5−74.0)
Months to censoring (min-max) 37.4 (0.8−91.3) 38.7 (0.8−89.2) 25.4 (0.6−90.3) 36.2 (0.6−91.3)
Continuous variables reported as median (range), categorical variables as number of dogs (percentage).
CCLD=Cranial Cruciate Ligament Disease; LFS= Lateral Fabellotibial suture; NA=Not applicable; OC=Osteochondrosis.
Table 3
Classification of cause of cranial cruciate ligament disease-related euthanasia in
61 dogs from a cohort study of 333 dogs (2011-2016).
Reason for euthanasia CCLD only Comorbidity Combined
N (%) N (%) N (%)
Persistent lameness 13 (52.0) 12 (48.0) 25 (41.0)
Contralateral CCLD 16 (94.1) 1 (5.9) 17 (28.9)
Other 2 (22.2) 7 (77.8) 9 (14.8)
Post-operative complications 7 (87.5) 1 (12.5) 8 (13.1)
Guarded prognosis 2 (100.0) 0 (0.0) 2 (3.3)
Total 40 (65.6) 21 (34.4) 61 (100)
CCLD=Cranial cruciate ligament disease.
Comorbidity= additional non−CCLD related factors contributing to the deci-
sion of euthanasia.
Guarded prognosis= prognosis perceived as guarded for return to full function
by either examining veterinarian or owner.
Fig. 1. Kaplan-Meier curves by treatment method describing survival in a cohort of 333 dogs with cranial cruciate ligament disease.
Table 4
Results from a multivariable Cox proportional hazards model of disease-related
survival in a cohort of 333 dogs with cranial cruciate ligament disease.
Variable and level Coeff. HR 95 % CI P
Treatment 0.035†
Conservative 1.00 – –
LFS −0.58 0.56 (0.28−1.14) 0.109
Osteotomy −0.91 0.40 (0.19−0.81) 0.012
Hospital
Hospital 1 1.00 – –
Hospital 2 0.20 1.21 (0.65−2.25) 0.547
Orthopaedic comorbidity < 0.001†
None 1.00 – –
Patellar luxation 0.45 1.57 (0.52−4.73) 0.420
Hip dysplasia 0.09 1.10 (0.34−3.59) 0.873
OC Stifle −0.24 0.78 (0.22−2.80) 0.706
Other 1.12 3.09 (1.59−6.00) 0.001
Age (years) 0.11 1.12 (1.01−1.25) 0.040
Weight (kg) 0.03 1.03 (1.01−1.05) 0.001
During the follow-up period a total of 61/333 dogs suffered disease-related
euthanasia. Age, weight and orthopaedic comorbidities at time of diagnosis.
HR = Hazard ratio, LFS= Lateral fabellotibial suture technique,
OC=Osteochondrosis.
† Wald-test.
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comorbidities, age and weight had a significant effect on survival. The
final multivariable overall survival model is presented in Table 5.
None of the tested interactions were significant in either model. In
both the disease-related and overall survival model, weight and age
were confounded with treatment method.
4. Discussion
Chronic clinical dysfunction due to persistent lameness resulting in
euthanasia is the most serious outcome of CCLD. This study is the first
to evaluate survival in dogs with CCLD. In total, 18.3 % of the dogs
were dead/euthanised of disease-related causes within the follow-up
time, which is substantially higher than the 2% reported by Mölsä et al.
(2013). Due to differences in study design and study samples, a direct
comparison of results is inappropriate and should be avoided. For ex-
ample, the study by Mölsä et al. (2013) was based on a questionnaire
completed by owners of 253 surgically treated dogs (followed for a
mean of 2.7 years), and it could be that owners of euthanised dogs were
less likely to return such a questionnaire. At one-year follow-up, 43/333
(12.9 %) dogs in the current study had died or been euthanised. This
finding supports the fact that exclusion of euthanised dogs has the
potential to bias the results in long-term studies evaluating clinical
function of dogs with CCLD.
Results from both the disease-related and the overall survival model
showed a favourable outcome for surgically treated dogs, with the
lowest hazard for dogs treated with osteotomy procedures. These
findings seem to be in line with the current evidence regarding long-
term outcome of dogs with surgically treated CCLD. The systematic
review by Bergh et al. (2014) concluded that, although the evidence is
too sparse to compare the effect of different treatment interventions,
there is some evidence in favour of TPLO as the preferred surgical
technique. One of the few randomised blinded controlled clinical trials
included in the systematic review was a study by Gordon-Evans et al.
(2013), which reported 1-year outcome after LFS and TPLO surgery in
80 dogs. The results indicated that both groups improved after surgery
and 93 % of owners were very satisfied after TPLO and 75 % after LFS.
Moreover, the superiority of osteotomy techniques in regard to func-
tional outcomes is also supported by the views of veterinary practi-
tioners and surgeons; a 2016 survey of American veterinary ortho-
paedic surgeons found that TPLO was the preferred surgical technique
for dogs> 15 kg (von Pfeil et al., 2018).
Further, in the current study there was a risk of treatment failure
resulting in euthanasia following conservative treatment. This finding is
supported by a study by Wucherer et al. (2013) including overweight
dogs> 20 kg followed for one year, where conservative treatment
resulted in a less favourable outcome than TPLO. It should, however, be
noted that the outcome was reported as successful in two-thirds of the
conservatively treated dogs. Since body weight was identified as a risk
factor in both survival models in the current study, with a lower hazard
for smaller dogs, it seems reasonable that conservative management
could still be a viable alternative in smaller dogs. These arguments can
explain why conservative treatment is commonly chosen for small dogs,
as reported in a recent UK surgeon survey by Comerford et al. (2013).
However, bodyweight is a widely known risk factor for survival in dogs
(irrespective of CCLD); large and giant breed dogs generally have a
shorter life span than smaller dogs (O’Neill et al., 2013). In the context
of CCLD, the lower hazard for smaller dogs observed in the current
study could potentially be confounded by the generally longer life ex-
pectancy in smaller dogs.
Orthopaedic comorbidity increased the risk of failure in the disease-
related survival model. A possible explanation is that the outcome
might be influenced by the co-existing condition. In addition, owners of
dogs with concurrent orthopaedic conditions could have perceived the
prognosis as more guarded than owners of dogs with an isolated CCLD.
Thus, they could be less motivated to pursue further treatment. In the
overall survival model, non-orthopaedic comorbidity increased the risk
of failure. This would be expected, since other diseases such as idio-
pathic epilepsy and heart failures are common reasons for euthanasia/
death in dogs, thereby influencing the overall survival (Bonnett et al.,
2005). As with the orthopaedic comorbidities, owners of dogs with non-
orthopaedic diseases might be more reluctant to proceed with treat-
ment of CCLD. A similar reasoning is likely to explain why the hazard of
death/euthanasia increased with age in both survival models. For the
overall survival, the effect of age on the hazard of death/euthanasia
increased over time, implying that death/the decision of euthanasia
was more influenced by age in older dogs compared with younger.
In our study, surgeons with different levels of experience performed
the procedures. The literature provides conflicting results regarding the
impact of the surgeon's experience on the outcome. While a few studies
have reported a positive correlation between surgeon experience and
outcome (Christopher et al., 2013), no association has been found in
several others (Pacchiana et al., 2003; Conzemius et al., 2005; Casale
and McCarthy, 2009; Gordon-Evans et al., 2013; Wilson et al., 2018). It
was not possible to determine the level of experience of the surgeons in
the present study; thus, the effect on survival could not be evaluated
and this should be acknowledged as a limitation. However, including
surgeons with different levels of experience could increase the external
validity of this study, since the outcome after procedures performed by
surgeons with variable levels of experience may more accurately reflect
common practice.
Joint exploration with meniscal inspection is generally re-
commended and has been performed in most studies of surgically
treated CCLD in dogs (Conzemius et al., 2005; Stauffer et al., 2006;
Fitzpatrick and Solano, 2010). It should be noted that joint exploration
was rarely performed in the conservatively treated dogs in the current
study. As such, undetected meniscal injury is a potential confounding
bias in the conservatively treated group.
There are some additional limitations in the current study that
should be mentioned. Importantly, survival only represents one aspect
of treatment outcome. The quality of life (QoL) for dogs with CCLD
should also be taken into consideration. Several standardised clinical
metrology instruments measuring chronic pain (HCPI and CBPI) or
function (COI) have been evaluated for assessment of musculoskeletal
disorders in dogs (e.g. Brown et al. (2007); Brown (2014); Hielm-
Bjorkman et al. (2009)). However, due to the long follow-up time in our
study, a high percentage of the dogs were dead at the time of follow-up.
Consequently, such assessments would only have provided results for a
selected group of dogs.
Moreover, the categorisation of the reasons for death/euthanasia
relied on the authors’ judgement, without further investigation or post-
mortem examinations. A decision of euthanasia is often complex and
Table 5
Results from a multivariable Cox proportional hazards model of overall survival
in a cohort of 333 dogs with cranial cruciate ligament disease.
Variable and level Coeff. HR 95 % CI P
Treatment 0.002†
Conservative 1.00 – –
LFS −0.63 0.53 (0.35−0.80) 0.003
Osteotomy −0.63 0.53 (0.35−0.81) 0.003
Hospital
Hospital 1 1.00 – –
Hospital 2 0.20 1.22 (0.85−1.77) 0.278
Non-orthopaedic comorbidity 0.42 1.53 (1.05−2.22) 0.028
Age (years) 0.11 1.12 (1.01−1.24) 0.028
Weight (kg) 0.03 1.03 (1.02−1.04) < 0.001
TVC (age) 0.00 1.00 (1.00−1.01) 0.006
During the follow-up period a total of 169/333 dogs where dead/euthanised.
Age, weight and non-orthopaedic comorbidities recorded at time of diagnosis.
HR = Hazard ratio, LFS= Lateral fabellotibial suture technique, TVC=Time-
varying covariate.
† Wald-test.
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disease-related survival is not a completely objective endpoint.
However, the results concerning disease-related survival were sup-
ported by the overall survival model. Any misclassification bias is
consequently likely to be non-differential and only reduce the like-
lihood to observe associations between exposures and the outcome.
The animal welfare legislation in Norway and Sweden supersedes
the EU regulations with more stringent requirements and a generally
higher standard for animal welfare than many other European countries
(Veissier et al., 2008). Thus, in both countries, it is common to regard
lameness as a welfare concern, and euthanasia is likely to be re-
commended when limb function is considered unacceptable. We be-
lieve this is important for the generalizability of the results in the
current study.
As this study was not conducted on a randomised group of patients,
the decision on which treatment to take for CCLD was not random.
Thus, both the initial treatment choice and the final decision of eu-
thanasia was likely influenced by inherent bias, including financial
considerations, and perceived risk and prognosis associated with the
treatment. It is likely that older dogs, and dogs with co-morbidities
were managed with cheaper methods (conservative, LFS) rather than
the more expensive osteotomy techniques. Likewise, owners investing
less in their pet may be more likely to choose euthanasia, rather than
treatment, for co-morbidities which are treatable, but comprehensive
and/or expensive to treat at the end of life. Since the present study was
conducted at referral hospitals, a selection bias towards complicated
cases cannot be excluded. Thus, it is possible that the success of con-
servative treatment in the target population may be better than in the
current study. As shown in Table 1, relatively more osteotomy proce-
dures were performed at hospital 1 compared to hospital 2. Thus,
choice of surgical technique was to some degree dependent on where
the procedure was performed, which is most likely due to differences in
routines and technique familiarity at the hospitals, in addition to the
preference of individual surgeons. This is in line with the survey by von
Pfeil et al. (2018) and illustrates that not only the signalment of the
dog, but also the surgeon’s preference are important determinants for
treatment choice. Although factors which could have directed the
treatment decision, such as hospital, insurance status, concurrent dis-
ease, weight and age of the dog were included in the analysis, un-
measured factors such as owners’ financial considerations and per-
ceived prognosis of both owners and clinicians likely influenced our
results.
5. Conclusion
Disease-related euthanasia due to CCLD was not uncommon in this
population of dogs, which shows that CCLD can affect life expectancy.
Both treatment strategy and variables related to signalment and history
of the dog were identified as risk factors for death/euthanasia.
Surgically treated dogs had a lower hazard compared to conservatively
treated dogs, which is in concordance with our hypothesis. In addition,
comorbidity and increasing age and weight increased the hazard.
Information regarding life expectancy in relation to risk factors is va-
luable facing a decision about treatment of CCLD.
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